ATR

ATR

USD

AptarGroup Inc. Common Stock

$149.060-1.790 (-1.187%)

リアルタイム価格

Healthcare
Medical Instruments & Supplies
米国

価格チャート

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$150.850

高値

$153.000

安値

$147.570

出来高

0.00M

企業ファンダメンタルズ

時価総額

10.0B

業種

Medical Instruments & Supplies

United States

取引統計

平均出来高

0.40M

取引所

NYQ

通貨

USD

52週レンジ

安値 $130.85現在値 $149.060高値 $178.03

AI分析レポート

最終更新: 2025年4月17日
AIによる生成データソース: Yahoo Finance, Bloomberg, SEC

[ATR: AptarGroup Inc.]: Sustainability Wins Meet Choppy Stock Chart - What's Next?

Stock Symbol: ATR Generate Date: 2025-04-17 16:08:59

Recent News Buzz: Green is Good, But Does it Move the Stock?

Let's talk about the news around AptarGroup (ATR). The vibe is definitely positive, focusing on their eco-friendly efforts. They just snagged a Platinum rating from EcoVadis again – for the fifth year running. That's like getting straight A's in sustainability, putting them in the top 1% across all industries EcoVadis looks at. Plus, Barron's named them one of the most sustainable US companies for the seventh time. Seven years! That's a long streak.

So, what does this mean? Basically, AptarGroup is serious about being green, and they're getting recognized for it. This kind of news is great for their reputation, and it can attract investors who care about sustainability. However, it's worth noting that these are awards for past actions. While good news, it doesn't tell us much about immediate sales or profits right now. Think of it as a good background hum for the company, but not necessarily a headline that will instantly send the stock price soaring today.

Price Check: Bumpy Ride Lately

Now, let's peek at the stock chart. Over the last month or so, ATR's price action has been a bit like a rollercoaster – not a smooth, predictable climb. If you look back to late January, the stock was hanging around the $157-$159 range. Then, around early February, things got shaky. There was a pretty noticeable drop, especially around February 7th, and the stock dipped down into the low $140s, even touching $142 at one point.

From mid-February through March, it tried to climb back up, hovering mostly in the $145-$147 range. Then, early April saw another dip, hitting lows around $130-$133. Since then, it's been trying to recover again. Today, it's around $145.40. So, to sum it up: downward pressure overall in the last month, with some bounces, but definitely not a clear uptrend. It's been a bit of a bumpy ride.

Interestingly, AI predictions are suggesting this bumpy ride might continue, at least in the very short term. They're forecasting a slight dip today and further drops over the next couple of days. However, it's just a prediction, and the market can always surprise.

Outlook & Ideas: Wait and See, But Keep an Eye On...

Putting it all together, what's the takeaway? The news is good for AptarGroup's image and long-term appeal, no doubt. But the stock price chart is telling a slightly different story – one of recent weakness and volatility. The AI predictions are adding to the short-term caution.

However, digging a bit deeper, there's another angle. Some technical indicators are actually flashing "bullish." Things like positive DMI, a potential bounce off a support level, and a surge in trading volume today suggest there might be some buying interest kicking in. Analysts also seem to like the stock, with strong buy ratings and a price target way up around $177. That's a good chunk of potential upside from where we are now.

So, what's the move? It's a bit of a mixed bag. The short-term AI prediction is negative, but some technical signals and analyst sentiment are more positive. Given the recent price weakness and the AI forecast, a cautious approach seems wise for now.

Potential Strategy Idea: Instead of jumping in headfirst, maybe consider a "wait and see" approach. If you're interested in ATR, keep an eye on that potential support level around $144.56 mentioned in the recommendation data. If the stock price holds above that and starts to show more consistent upward movement, it might be a point to consider a small entry.

Think about a potential entry around the current price level ($145) or perhaps on a slight dip towards $144, if it happens. If you do enter, consider setting a stop-loss to manage risk. A level around $139.12, as suggested in the recommendation data, could be a reasonable point to protect yourself if the price drops further. For a potential take-profit, the analyst target of $177 is quite high. A more conservative initial target might be closer to recent resistance levels, perhaps around $148-$150, and then reassess.

Important Note: This is just one possible way to look at the data. The market is unpredictable, and things can change quickly. The AI prediction is negative short-term, so caution is definitely warranted.

Company Snapshot: Healthcare & Sustainability Focus

Quick reminder about AptarGroup itself: they're in the medical instruments and supplies business, part of the healthcare sector. They make things like drug delivery systems and dispensing solutions. So, sustainability in packaging and operations is probably pretty relevant to their customers and their overall business image. Keep that in mind when weighing the news about their sustainability awards.


Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Trading stocks involves risk, and you could lose money. Always do your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

関連ニュース

Analyst Upgrades

Raymond James Maintains Outperform on AptarGroup, Lowers Price Target to $175

Raymond James analyst Matt Roberts maintains AptarGroup with a Outperform and lowers the price target from $190 to $175.

もっと見る
Raymond James Maintains Outperform on AptarGroup, Lowers Price Target to $175
BusinessWire

Aptar Declares Quarterly Dividend

AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today declared a quarterly cash dividend of $0.45 per share. The payment date is May 22, 2025, to

もっと見る
Aptar Declares Quarterly Dividend
BusinessWire

Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year

Places in top 1% of EcoVadis' rankings for all industries AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, has achieved the Platinum level rating

もっと見る
Aptar Receives Platinum Rating from EcoVadis for the Fifth Consecutive Year

AI予測Beta

AI推奨

弱気

更新日時: 2025年4月28日 06:27

弱気中立強気

63.5% 信頼度

リスクと取引

リスクレベル3/5
中リスク
適しているのは
中程度
取引ガイド

エントリーポイント

$148.32

利確

$152.03

損切り

$143.87

主要因子

PDI 6.9はMDI 5.0の上にあり、ADX 12.6とともに強気トレンドを示唆しています
現在の価格はサポートレベル(148.72ドル)に非常に接近しており、強力な買い機会を示唆しています
出来高は平均(3,785)の5.2倍で、極めて強い買い圧力を示しています
MACD 0.1637はシグナルライン0.1117の上にあり、強気クロスオーバーを示しています

最新情報を入手

価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。